Showing 1 - 10 of 334,556
industry activities proceeds, national regulation aimed at reducing costs for pharmaceuticals can have the unintended effect of …This paper looks into various means of regulating pharmaceuticals and their effects on the structure of the … international pharmaceutical industry. Regulation adds complexity to the activities of a firm. This complexity is multiplied, if …
Persistent link: https://www.econbiz.de/10013127115
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … also characterized by extensive regulation of almost every activity, from product development through manufacturing and …
Persistent link: https://www.econbiz.de/10014025576
regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …
Persistent link: https://www.econbiz.de/10010477153
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals …
Persistent link: https://www.econbiz.de/10010462523
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10010339324
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals …
Persistent link: https://www.econbiz.de/10010467805
We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...
Persistent link: https://www.econbiz.de/10012295656
manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …
Persistent link: https://www.econbiz.de/10011986314
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the … of the content regulation is ambiguous and depends, among other things, on the cost effectiveness of advertisement and …
Persistent link: https://www.econbiz.de/10012024745